This is tasty and nutritious risotto recipe has a twist – rice is swapped for the high-protein grain, quinoa. Tender wild mushrooms combine with crunchy quinoa to create a dish with exciting textures. This vegetarian recipe can be adapted for people with chewing or swallowing problems by blending ingredients to the required consistency
1.2l vegetable stock
2 tbsp olive oil
200g chestnut mushrooms
100g red sweet pepper 100g red onion 100g sweet corn kernels (canned) 1 garlic clove
1 glass white wine 1 teaspoon red wine vinegar
1 lemon ½ tbsp thyme, ½ tbsp oregano ½ tbsp rosemary ½ tbsp salt and pepper
Cook the quinoa in vegetable stock as indicated on the package.
Dice the peppers and onion. Slice the mushrooms.
Finely chop the garlic.
Pour the sweet corn kernels (from the can) into a sieve and leave to drain.
Fry the vegetables in olive oil.
Add the herbs and garlic, season with pepper and salt. Stir well.
Deglaze with white wine, reduce by half.
Add the pre-cooked quinoa and corn kernels.
Just before serving season with some drops of red wine vinegar and/or lemon juice.
WPC Scientific Update 2015: the low-down on latest advances
Webcast gives free access to pioneering Parkinson's science
1 month ago
Could a transplant lower the risk of Parkinson’s?
Researchers at Washington University School of Medicine, US, have found that having a heart, kidney, lung or bone marrow transplant could reduce the risk of developing Parkinson’s. As part of the study, published in medical journal ‘Parkinsonism & Related Disorders’, the team assessed data of just under 200,000 patients – 89,790 of whom had Parkinson’s. The results revealed that individuals who had a transplant were 37% less likely to develop Parkinson’s. This could be due to the immunosuppressant medication patients receive before undergoing a transplant, which researchers believe may help slow neurodegeneration as it reduces inflammation in the brain. The study said: “This study provides evidence that tissue transplant may be associated with a lower PD [Parkinson’s disease] risk, warranting further investigation to identify factors that mediate this relationship.”
A breakthrough Parkinson’s trial that featured in a two-part documentary on UK television channel BBC Two has published its results. The study, which featured in the documentary ‘The Parkinson’s Drug Trial: A miracle cure?’, aimed to investigate whether it was possible to restore damaged neurons by administering protein Glial Cell Line Derived Neurotrophic Factor (GDNF). As part of the trial, scientists initially infused GDNF into the brains of six participants living with the condition. Researchers then invited a further 35 individuals with Parkinson’s to take part, with approximately half being administered with a placebo infusion. Although not conclusive, the results suggest that GDNF had an impact on the brain and researchers believe the topic is worthy of further study. Dr Alan Whone, principal investigator on the trial, said: “This represents some of the most compelling evidence yet that we may have a means to possibly reawaken and restore the dopamine brain cells…
Course for Parkinson’s nurses launches in Slovenia
The International Parkinson and Movement Disorder Society is hosting its third summer school for nurses specialising in Parkinson’s. The course – which will be held from 10-12 May in Ljubljana, Slovenia – will focus on the management of the motor and non-motor symptoms of the condition. Students will also attend lectures, examine Parkinson’s patients and discuss treatment plans with experts. All lectures will be presented in English. Heather Vitale, senior programme manager at the International Parkinson and Movement Disorder Society, said: “This course offers a unique opportunity for nurses to enhance their knowledge in Parkinson’s disease, while also learning and networking with their peers through case study presentations and small group discussions.” Registration closes 26 April 2019 and costs USD $350.